Common Stock, Shares, Issued of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025
- Taxonomy & unit
- us-gaap: shares
- Description
- Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
- Summary
-
Universe Pharmaceuticals INC quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Sep 2020 to 30 Sep 2025.
- Universe Pharmaceuticals INC Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 563,338, a 1214% increase year-over-year.
- Source SEC data
- View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)
Universe Pharmaceuticals INC Quarterly Common Stock, Shares, Issued (shares)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | 563,338 | +520,458 | +1214% | 30 Sep 2025 | 20-F | 29 Jan 2026 | 2025 | FY |
| Q3 2024 | 42,880 | +36,818 | 30 Sep 2024 | 20-F | 29 Jan 2026 | 2025 | FY | |
| Q1 2024 | 3,645,974 | +20,974 | +0.58% | 31 Mar 2024 | 6-K | 20 Sep 2024 | 2024 | Q2 |
| Q3 2023 | 6,062* | -3,618,938 | 30 Sep 2023 | 20-F | 29 Apr 2025 | 2024 | FY | |
| Q1 2023 | 3,625,000 | -18,125,000 | -83% | 31 Mar 2023 | 6-K | 31 Aug 2023 | 2023 | Q2 |
| Q3 2022 | 3,625,000 | -18,125,000 | -83% | 30 Sep 2022 | 20-F | 30 Jan 2024 | 2023 | FY |
| Q1 2022 | 21,750,000 | 31 Mar 2022 | 6-K | 16 Aug 2022 | ||||
| Q3 2021 | 21,750,000 | +5,750,000 | +36% | 30 Sep 2021 | 20-F | 10 Feb 2023 | 2022 | FY |
| Q3 2020 | 16,000,000 | 30 Sep 2020 | 20-F | 31 Jan 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.